Literature DB >> 17661420

Determining the model for end-stage liver disease with better accuracy: neutralizing the international normalized ratio pitfalls.

Richard A Marlar.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17661420     DOI： 10.1002/hep.21833

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

Review 1.  Model for end-stage liver disease: end of the first decade.

Authors:  Sumeet K Asrani; W Ray Kim
Journal:  Clin Liver Dis       Date:  2011-10-01       Impact factor: 6.126

Review 2.  Changing Concepts of Cirrhotic Coagulopathy.

Authors:  Armando Tripodi; Massimo Primignani; Pier M Mannucci; Stephen H Caldwell
Journal:  Am J Gastroenterol       Date:  2016-11-01       Impact factor: 10.864

Review 3.  Model for end-stage liver disease score and MELD exceptions: 15 years later.

Authors:  Sumeet K Asrani; Patrick S Kamath
Journal:  Hepatol Int       Date:  2015-05-28       Impact factor: 6.047

4.  Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests.

Authors:  Guido M Kukuk; Stephanie G Schaefer; Rolf Fimmers; Dariusch R Hadizadeh; Samer Ezziddin; Ulrich Spengler; Hans H Schild; Winfried A Willinek
Journal:  Eur Radiol       Date:  2014-07-17       Impact factor: 5.315

5.  The international normalized ratio of prothrombin time in the model for end-stage liver disease score: a reliable measure.

Authors:  Patrick S Kamath; W Ray Kim
Journal:  Clin Liver Dis       Date:  2009-02       Impact factor: 6.126
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.